Also, TM7SF2’s involvement in tumorigenesis, particularly in differentiating non-aggressive and aggressive follicular carcinomas in the thyroid, underscored its potential as a diagnostic biomarker in cancer management [18]. The gene discussed is TM7SF2; the disease is thyroid gland follicular carcinoma.